Market Value312,755,171
Total Holdings61
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
INBX / Inhibrx Biosciences, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
DOV / Dover Corporation
/ VENTYX BIOSCIENCES INC
COGT / Cogent Biosciences, Inc.
PTGX / Protagonist Therapeutics, Inc.
ROIV / Roivant Sciences Ltd.
CL / Colgate-Palmolive Company
LLY / Eli Lilly and Company
JNJ / Johnson & Johnson
UA / Under Armour, Inc.
PRU / Prudential Financial, Inc.
FGEN / FibroGen, Inc. Put
AVDL / Avadel Pharmaceuticals plc
VRTX / Vertex Pharmaceuticals Incorporated
ARCT / Arcturus Therapeutics Holdings Inc.
FEMY / Femasys Inc.
ISRG / Intuitive Surgical, Inc.
WST / West Pharmaceutical Services, Inc.
CBAY / CymaBay Therapeutics, Inc.
AM / Antero Midstream Corporation
ARGX / argenx SE - Depositary Receipt (Common Stock)
FAST / Fastenal Company
MRTX / Mirati Therapeutics, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
EDIT / Editas Medicine, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
ILMN / Illumina, Inc.
GKOS / Glaukos Corporation
CTAS / Cintas Corporation
IMTX / Immatics N.V.
RITM / Rithm Capital Corp.
AMGN / Amgen Inc.
KMI / Kinder Morgan, Inc.
KVUE / Kenvue Inc. Call
MRSN / Mersana Therapeutics, Inc.
RES / RPC, Inc.
NARI / Inari Medical, Inc.
NTRA / Natera, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
NUVL / Nuvalent, Inc.
GERN / Geron Corporation
HIG / The Hartford Insurance Group, Inc.
SDGR / Schrödinger, Inc.
TVTX / Travere Therapeutics, Inc.
PSEC / Prospect Capital Corporation
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
SLRN / Acelyrin, Inc.
RXRX / Recursion Pharmaceuticals, Inc.
GCMG / GCM Grosvenor Inc.
ETNB / 89bio, Inc.
APH / Amphenol Corporation
JBLU / JetBlue Airways Corporation
PEAK / Healthpeak Properties, Inc.
HSY / The Hershey Company
REGN / Regeneron Pharmaceuticals, Inc.
CTLT / Catalent, Inc.
ELV / Elevance Health, Inc.
BRK.A / Berkshire Hathaway Inc.
AXSM / Axsome Therapeutics, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
SPY / SPDR S&P 500 ETF
MORF / Morphic Holding, Inc.
NMRK / Newmark Group, Inc.
DXCM / DexCom, Inc.
PMVP / PMV Pharmaceuticals, Inc.
TEL / TE Connectivity plc
ITW / Illinois Tool Works Inc.
MLTX / MoonLake Immunotherapeutics
GEHC / GE HealthCare Technologies Inc.
VTRS / Viatris Inc.
MDT / Medtronic plc
ALDX / Aldeyra Therapeutics, Inc.
YUM / Yum! Brands, Inc.
UPS / United Parcel Service, Inc.
SWN / Southwestern Energy Company
ABBV / AbbVie Inc.
XENE / Xenon Pharmaceuticals Inc.
ALPN / Alpine Immune Sciences, Inc.
MRUS / Merus N.V.
ATXS / Astria Therapeutics, Inc.
SILK / Silk Road Medical, Inc
IRWD / Ironwood Pharmaceuticals, Inc.
VERA / Vera Therapeutics, Inc.
UAA / Under Armour, Inc.
XFOR / X4 Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
STVN / Stevanato Group S.p.A.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
MDGL / Madrigal Pharmaceuticals, Inc.
PRAX / Praxis Precision Medicines, Inc.
IMGN / ImmunoGen, Inc.